TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by
EPR17341
Merkel cell carcinoma
NTRK1
NTRK2
NTRK3
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
06 Dec 2022
06 Dec 2022
Historique:
received:
01
11
2022
revised:
01
12
2022
accepted:
05
12
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignant tumor with neuroendocrine differentiation, with a rapidly growing incidence rate, high risk of recurrence, and aggressive behavior. The available therapeutic options for advanced disease are limited and there is a pressing need for new treatments. Tumors harboring fusions involving one of the neurotrophin receptor tyrosine kinase (
Identifiants
pubmed: 36499693
pii: ijms232315366
doi: 10.3390/ijms232315366
pmc: PMC9737899
pii:
doi:
Substances chimiques
Receptor, trkA
EC 2.7.10.1
Nerve Growth Factors
0
Receptor, trkC
EC 2.7.10.1
Oncogene Proteins, Fusion
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Veneto Institute of Oncology (IOV)-I.R.C.C.S
ID : project 5x1000, section Sinergia, title PROSOFT
Références
J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1708-1713
pubmed: 27136306
Nat Med. 2013 Nov;19(11):1469-1472
pubmed: 24162815
JCO Precis Oncol. 2018;2018:
pubmed: 30215037
Nat Genet. 1998 Feb;18(2):184-7
pubmed: 9462753
Histopathology. 2006 May;48(6):748-53
pubmed: 16681692
Ther Clin Risk Manag. 2018 Jul 20;14:1247-1252
pubmed: 30050303
Mod Pathol. 2020 Jan;33(Suppl 1):42-55
pubmed: 31676786
Nat Rev Clin Oncol. 2018 Dec;15(12):763-776
pubmed: 30287935
Am J Surg Pathol. 2000 Jul;24(7):937-46
pubmed: 10895816
Histopathology. 2019 Jul;75(1):54-62
pubmed: 30801752
Development. 2002 Aug;129(15):3739-50
pubmed: 12117822
Front Oncol. 2020 Apr 15;10:529
pubmed: 32351898
Eur J Cancer. 2018 May;94:47-60
pubmed: 29533867
Eur J Cancer. 2017 Jan;71:53-69
pubmed: 27984768
Cancer Res. 2019 Jul 1;79(13):3163-3168
pubmed: 31196931
Oncotarget. 2018 Nov 9;9(88):35809-35812
pubmed: 30533196
Clin Lung Cancer. 2021 Sep;22(5):e712-e715
pubmed: 33714692
J Plast Reconstr Aesthet Surg. 2014 Mar;67(3):e71-7
pubmed: 24125874
Arch Pathol Lab Med. 2021 Aug 1;145(8):1031-1040
pubmed: 33112951
JAMA Dermatol. 2017 Mar 1;153(3):296-303
pubmed: 28097368
Cancer Res. 2015 Dec 15;75(24):5228-34
pubmed: 26627015
Cancer Cell. 2002 Nov;2(5):367-76
pubmed: 12450792
Nat Rev Dis Primers. 2017 Oct 26;3:17077
pubmed: 29072302
Cancer Res. 2015 Sep 15;75(18):3720-3727
pubmed: 26238782
Clin Cancer Res. 2020 Apr 1;26(7):1624-1632
pubmed: 31871300
Emerg Infect Dis. 2009 Mar;15(3):489-91
pubmed: 19239773
J Immunother Cancer. 2022 Jun;10(6):
pubmed: 35701070
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Oncotarget. 2016 Jan 19;7(3):3403-15
pubmed: 26655088
Clin Cancer Res. 2019 Oct 1;25(19):5961-5971
pubmed: 31399473
Mod Pathol. 2022 Mar;35(3):298-305
pubmed: 34531526
Am J Surg Pathol. 2010 May;34(5):599-608
pubmed: 20410810
Front Oncol. 2021 Dec 17;11:737842
pubmed: 34976795
Int J Mol Sci. 2021 Nov 15;22(22):
pubmed: 34830218
Am J Surg Pathol. 2019 Dec;43(12):1693-1700
pubmed: 31498178
Ann Surg Oncol. 2016 Oct;23(11):3564-3571
pubmed: 27198511
Cell Host Microbe. 2010 Jun 25;7(6):509-15
pubmed: 20542254
Mod Pathol. 2020 Jan;33(1):38-46
pubmed: 31375766
Eur J Cancer. 2015 Nov;51(16):2396-403
pubmed: 26257075
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747
pubmed: 30333516
JAMA Dermatol. 2014 Aug;150(8):864-72
pubmed: 24943712
Eur J Dermatol. 2021 Dec 1;31(6):691-701
pubmed: 35107067
Clin Cancer Res. 2019 Aug 1;25(15):4712-4722
pubmed: 31028088
Arch Pathol Lab Med. 2011 Dec;135(12):1606-10
pubmed: 22129193
Development. 2017 Nov 15;144(22):4078-4090
pubmed: 29138290